Literatur
- 1
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P.
Estimates of the cancer incidence and mortality in Europe in 2006.
Annals of Oncology.
2006;
DOI: 10.1.093/annonc/imd498
- 2 Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. und das Robert
Koch-Institut .Krebs in Deutschland - Häufigkeiten und Trends. ed 5. überarbeitete,
aktualisierte Auflage. Saarbrücken ; RoBo Print, Riegelsberg 2006
- 3
Brenner H, Stegmaier C, Ziegler H.
Verbesserte Langzeitüberlebensraten von Krebspatienten. Die unterschätzten Fortschritte
der Onkologie.
Dtsch Ärztebl.
2005;
102
2628-2633
- 4 Albert U S, Schulz K D, Kopp I. Leitlinien-Methodenreport: Aktualisierung der Stufe-3-Leitlinie
Brustkrebs-Früherkennung in Deutschland 2007. ed konsultierte Fassung Version 1.1.
Marburg: http//www.awmf-leitlinien.de
. 2007
- 5
Lorenz W, Ollenschläger G, Geraedts M, Gerlach F, Gangjour A, Helou A, Kirchner H,
Koller M, Lauterbach W, Reinauer H, Sitter H, Thomeczek C.
Das Leitlinien Manual: Entwicklung und Implementierung von Leitlinien in der Medizin.
ZaeFQ.
2001;
95
1-84
- 6
Encke A, Kopp I, Selbmann H, Hoppe J, Köhler A, Ollenschläger G. Arbeitsgemeinschaft
der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) .
Deutsches Instrument zur methodischen Bewertung von Leitlinien: DELBI.
Dt Ärztebl.
2006;
102
A1912-A1913
- 7
Kopp I, Encke A, Lorenz W.
Leitlinien als Instrument der Qualitätssicherung in der Medizin.
Bundesgesundheitsbl-Gesundheitsforsch-Gesundheitsschutz.
2002;
45
223-233
- 8 Nothacker M, Lelgemann M, Giersiepen K, Weinbrenner S. Evidenzbericht 2007 zur S‐3-Leitlinie
Brustkrebsfrüherkennung in Deutschland. Band 31. ed Version 1.00. Berlin ; Ärztliches
Zentrum für Qualität in der Medizin (ÄZQ) http://www.aezq.de/publikationen0index/schriftenreihe/view,
http://www.awmf-leitlinien.de 2007
- 9 Schulz K D, Albert U S. und die Mitglieder der Arbeitsgruppe „Konzertierte Aktion:
Brustkrebs-Früherkennung in Deutschland“ .Stufe 3 Leitlinie Brustkrebs-Früherkennung
in Deutschland. ed 1. München ; Zuckschwerdt Verlag 2003
- 10 Perry N, Broeders M, Wolf de C, Törnberg S, Holland R, Karsa von L. European guidelines
for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg
; European Communities Publication, 2006
- 11 World Health Organisation (WHO) .National Cancer Control Programms: Policies and
managerial Guidelines. 2nd ed. Geneva, Italy ; Health and Development Networks (HDN),
2002
- 12 Hoffmann W, Latza U, Terschüren C, Berger K, Bergmann M, Dahl A, Fendrich K, Gierer S,
Holle R, Jahn I, Schümann M, Steindorf K. Leitlinien und Empfehlungen zur Sicherung
von Guter Epidemiologischer Praxis (GEP) - Langversion. 2. Aufl. mit Änderungen nach
Evaluation. Münster: Arbeitsgruppe Epidemiologischer Methoden der Deutschen Arbeitsgemeinschaft
für Epidemiologie (DAE); Deutsche Gesellschaft für Medizinische Informatik, Biometrie
und Epidemiologie (GMDS); Deutsche Gesellschaft für Sozialmedizin und Prävention (DGSMP);
Deutsche Regionen der Internationalen Biometrischen Gesellschaft (DR‐IBS); 1. Aufl.:
Kurth BM, Hense HW, Hoffmann W, Ahrens W, Babitsch B, Becher H, Blettner M, Brasche
S, Brenner H, Enderlein G, Greiser KH, Jahn I, Jöckel KH, Kirschner W, Kohlmann T,
Liese A, Möhner M, Mueller U, Reintjes R, Stang A, Wyst M. http://www.medweb.uni-muenster.de/institute/epi/dae/vorstand.html
. , 2004
- 13 NBCC National Breast Cancer Center .Clinical practice guidelines for the management
of early breast cancer. ed i Soruce. Australia ; NBCC National Breast Cancer Center
(http://www.nbcc.org.au), 2001
- 14
Smith R, Saslow D, Sawyer K, Burke W, Costanza M, Evans W, Foster Jr. R, Hendrick E,
Eyre H, Sener S.
American Cancer Society guidelines for breast cancer screening. Update 2003.
CA Cancer Journal of Clinicans.
2003;
53
141-169 (http://www.caonline.amcancersoc.org/cgi/content/full/53/3/141)
- 15
Brett J, Bankhead C, Henderson B, Watson E, Austoker J.
The psychological impact of mammographic screening. A systematic review.
Psycho-Oncology.
2005;
14
917-938
- 16
Albert U S, Schulz K D, Alt D, Beck V, Doherty J, Holsteg K, Kalbheim E, Müller J,
Nass-Griegoleit I, Nill J, Nioduschewski G, Schulte H, Wietersheim von A, Kopp I.
Eine Leitlinie für Leitlinien: die methodische Entwicklung und Anwendung der Leitlinie
Fraueninformation.
Zentralbl Gynakol.
2003;
125
484-493 (AWMF Reg. Nr.: 077-002; www.awmf-leitlinien.de)
- 17 NHS Centre for Reviews and Dissemination .Effective Health Care: Informing, communicating
and sharing decision with people who have cancer. Plymouth ; Latimer Trend & Company
Ltd 2000
- 18 NCCN National Comprehensive Cancer Network .Breast Cancer. USA: NCCN Clinical Practice
Guidelines in Oncology ( www.nccn.org). 2006
- 19 NCCN National Comprehensive Cancer Network .Breast cancer screening and diagnosis
guidelines. USA: NCCN Clinical Practice Guidelines in Oncology (http://www.nccn.org). 2007
- 20 Calman K, Hine D, Peto R, Boreham J, Clarke M, Purushotham A, Pain S, Miles D.
NICE: Improving outcomes in breast cancer. London ; NICE 2002
- 21 NICE NCCfPC .Familial breast cancer - The classification and care of women at risk
of familial breast cancer in primary, secondary and tertiary care. Update July 2006.
NICE (www.nice.org.uk/CG041). 2006
- 22 SIGN Scottish Intecollegiate Guideline Network .Management of breast cancer in
women. Edinburgh ; SIGN (www.sign.ac.uk) 2005
- 23
Smith R, Caleffi M, Albert U S, Chen T, Duffy S, Franceschi D, Nyström L.
Breast cancer in limited-resource countries: Early detection and access to care.
The Breast J.
2006;
12
S16-S26
- 24 NICE .NICE clinical guideline no 27: Referral guidelines for suspected cancer.
NICE (www.nice.org.uk/CG027). 2005
- 25 NBCC .The investigation of a new breast symptom - a guide for GP. Australia: NBCC
(http://www.nbcc.org.au). 2006
- 26 NBCC .Position Statement early detection of breast cancer. In: NBCC (ed). Canberra
; National Health and Medical Research Council (http://www.nbcc.org.au) 2004
- 27 NBCC National Breast Cancer Centre .Evidence relevant to guidelines for the investigation
of breast symptoms. 2nd ed. Camperdown, Australia ; National Breast Cancer Centre
(www.nbcc.org.au) 2006
- 28 NBCC .Clinical practice guidelines for the management and support of younger women
with breast cancer. 1st ed. Camperdown, NSW ; National Health and Medical Research
Council (NHMRC) (http://www.nbcc.org.au) 2004
- 29
Gotzsche P C, Nielsen M.
Screening for breast cancer with mammography.
Cochrane Database of Systematic Reviews.
2006;
DOI: Art.No: CD001877, 101002/14651858.CD001877.pub2
- 30 AMERICAN COLLEGE OF RADIOLOGY (ACR) .Breast Imaging Reporting and Data System (BIRADS™).
4th ed. Reston VA ; American College of Radiology 2003
- 31
Katalinic A, Bartel C, Raspe H, Schreer I.
Beyond mammography screening: quality assurance in breast cancer diagnosis.
Br J Cancer.
2007;
96
157-161
- 32
Schreer I, Katalinic A.
Is high quality breast imaging and diagnosis possible in a decentralized system?.
Breast Care.
2007;
2
20-24
- 33
Madjar H, Ohlinger R, Mundinger A, Watermann D, Frenz J, Bader W, Schulz-Wendlandt R,
Degenhardt F.
BI-RADS analoge DEGUM Kriterien von Ultraschallbefunden der Brust - Konsensus des
Arbeitskreises Mammosonographie der DEGUM.
Ultraschall in Med.
2006;
27
374-379
- 34 NCCN National Comprehensive Cancer Network .Clinical Practice Guidelines in Oncology:
Genetic/Familial High-Risk Assessment: Breast and Ovarian. NCCN Clinical Practice
Guidelines in Oncology. USA: Clinical Practice Guidelines in Oncology (http://www.nccn.org). 2007
- 35
Schwartz G, Veronesi U, Clough K, Dixon J, Fentima I, Heywang-Köbrunner S, Hughes K,
Mansel A, Mangolese R, Mendelson E, Olivotte J, Palazzo J, Solin L.
Consensus Conference on Breast Conservation. Milan, Italy, April 28 - May 1, 2005.
Cancer.
2006;
107
242-250
- 36 NICE .Breast Cancer: Diagnosis and Treatment. UK: NICE (http://www.nice.org.uk). 2006
- 37
Crystal P, Koretz M, Shcharynsky S, Makarov V, Strano S.
Accuracy of sonographically guided 14-gauge core-needle biopsy: Result of 715 consecutive
breast biopsies with at least two-year follow-up of benign lesions.
J Clin Ultrasound.
2004;
33
47-51
- 38
Fishman J, Milikowski C, Ramsinghani R, Velasquez M, Aviram G.
US-guided core-needle biopsy of the breast: How many specimens are necessary?.
Radiology.
2003;
226
779-782
- 39 NICE .Image-guided vacuum-assisted excision biopsy of benign breast lesions. UK:
NICE (http://www.nice.org.uk/IPG156). 2006
- 40 O'Higgins N, Linos D A, Blichert-Toft M, Cataliotti L, Wol de C, Rochard F, Rutgers E,
Roberts P, Mattheim W, da Silva M A, Holmberg L, Schulz K D, Smola M G, Mansel R E.
European Guidelines for Quality Assurance in the Surgical Management of Mammographically
Detected Lesions. Perry N, Broeders M, de Wolf C, Toernberg S, Holland R, von Karsa
L European Guidelines for Quality Assurance in Breast Cancer Sreening and Diagnosis
Luxembourg ; Office for official publication of the European Communities 2006: 315-320
- 41 Carlson R, Anderson B, Burstein H. NCCN Breast Cancer Clinical practice guidelines
in Oncology. USA: National Comprehensive Cancer Network (http://www.nccn.org). 2005
- 42 Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W, Borisch B, Bussolati G,
Connolly C, Cserni G, Decker K, Dervan P, Drijkoningen M, Ellis I O, Elston C, Eusebi V,
Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquermier J, Lacerda M, Martinez-Penuela J,
De Miquel C, Nordgren H, Peterse J L, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafari B,
Tanous A, Thorstenson S, Zozoya E, Wells C. Quality assurance guidelines for pathology:
open biopsy and resection specismens. Wells C European Guidelines for Quality Assurance
in Breast Cancer Screening and Diagnosis Luxembourg; Office for Official Publications
of the European Communities 2006: 257-311
- 43 NHSBP .Guidelines for non-operative diagnostic procedures and reporting in breast
cancer screening (vol NHSBP Publication No. 50). Sheffield ; NHS Cancer Screening
Programmes 2001
- 44 Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W, Borisch B, Bussolati G,
Connolly C, Cserni G, Decker K, Dervan P, Drijkoningen M, Ellis I O, Elston C, Eusebi V,
Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquermier J, Lacerda M, Martinez-Penuela J,
De Miquel C, Nordgren H, Peterse J L, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafari B,
Tanous A, Thorstenson S, Zozoya E, Wells C. Quality assurance guidelines for pathology:
Cytological and histological non-operative procedures. Wells C European Guidelines
for Quality Assurance in Breast Cancer Screening and Diagnosis Luxembourg ; Office
for Official Publications of the European Communities 2006: 221-256
- 45 WHO .Pathology and genetics of tumours of the breast and female genital organs. Tavassoli
F, Devilee P WHO. World Health Organization Classification of Tumours Lyon ; IACR
Press 2003: 9-112
- 46
Silverstein M J, Poller D N, Waisman J R, Colburn W J, Barth A, Gierson E D, Lewinsky B,
Gamagami P, Slamon D J.
Prognostic classification of breast ductal carcinoma-in-situ.
Lancet.
1995;
345
1154-1157
- 47 ICSI .Diagnosis of breast disease - guideline ICSI. update 2005. ICSI (http://www.icsi.org). 2005
- 48
The Association of Breast Surgery at BASO, RCoSoE .
Guidelines for the management of symptomatic breast disease.
Eur J Surg Oncol.
2005;
31
S1-S21
- 49 Sobin L, Wittekind C. UICC.TNM Classification of malignant tumours. 6th ed. New
York ; A. John Wiley & Sons Inc. Publication 2002
- 50
Wolff A, Hammond M, Schwartz J, Hagerty K, Allred D, Cote R, Dowsett M, Fitzgibbons P,
Hanna W, Langer A, McShane L, Paik S, Pegram M, Perez E, Press M, Rhodes A, Sturgeon C,
Taube S, Tubbs R, Vance G, vanD V, Wheeler T, Hayes D.
American Society of Clinical Oncology/College of American Pathologists guideline recommendations
for human epidermal growth factor receptor 2 testing in breast cancer.
J Clin Oncol.
2007;
25
145
- 51
Elston C W, Ellis I O.
Pathological prognostic factors in breast cancer. 1. The value of histological grade
in breast cancer: experience from a large study with long-term follow-up.
Histopathology.
1991;
19
403-410
- 52
Harvey J M, Clark G M, Osborne C K, Allred D C.
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding
assay for predicting response to adjuvant endocrine therapy in breast cancer.
J Clin Oncol.
1999;
17
1474-1481
- 53
Remmele W, Stegner H E.
Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical
estrogen receptor detection (ER‐ICA) in breast cancer tissue.
Pathologe.
1987;
8
138-140
- 54 National Quality Management Committee of Breast Screen .Australia: Breastscreen
Australia - National Accreditation Standards 2004 (http://www.breastscreen.info.au). 2004
- 55 NHMRC .Psychosocial clinical practice guideline. Australia: NHMRC (http://www.nhmrc.health.gov.au). 1999
- 56 Philipps B, Sackett D, Badenoch D, Strauss S, Haynes B, Dawes M. Level of Evidence
and Grade of Recommendation. Oxford ; Centre of Evidence Based Medicine, Oxford 2001
(Dt. autorisierte Übersetzung: Schlömer G. FR Gesundheit, Universität Hamburg, www.gesundheit.uni-hamburg.de/upload/EVIBAG_methodik_GS_1702.doc)
- 57 Bundesärztekammer .AWMF, Kassenärztliche Vereinigung (Hrsg). Programm für Nationale
Versorgungsleitlinien - Methodenreport. 3. Auflage. Berlin:. ÄZQ (www.methodik.n-v-l.de)
2007
1 Ständige Leitlinienkommission der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen
Fachgesellschaften
PD Dr. med. Ute-Susann Albert
Koordination: Konzertierte Aktion Brustkrebs-Früherkennung in Deutschland
c/o Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Gynäkologie, gynäkologische Endokrinologie und Onkologie
Brustzentrum Regio
Baldingerstraße
35043 Marburg
Email: albertu@med.uni-marburg.de
